Larotrectinib
Records for this ingredient, by country (identity only).
ATC L01EX12 · 8 markets · 29 records
US 7 records · 3 shown of 3
GB 4 records · 3 shown of 3
- 100 mgcapsuleVITRAKVI
- 25 mgcapsuleVITRAKVI
- 20 mg per mL / per unit basis not statedliquidVitrakvi 20mg/ml oral solution
AU 4 records · 3 shown of 3
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 3 records · 3 shown of 3
- 100 mgcapsuleVITRAKVI維泰凱 膠囊100毫克
- 25 mgcapsuleVITRAKVI維泰凱 膠囊25毫克
- 20 mg per mL / per unit basis not statedliquidVitrakvi 20mg/ml oral solution維泰凱20毫克/毫升口服溶液
HK 3 records · 0 shown of 0
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 3 records · 3 shown of 3
- 100 mgcapsuleヴァイトラックビカプセル100mg
- 25 mgcapsuleヴァイトラックビカプセル100mg
- 2 %/1 mLotherヴァイトラックビ内用液20mg/mL
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | AU | ES | TW | HK | JP | EU |
|---|---|---|---|---|---|---|---|---|
| 100 mg capsule | VITRAKVI | VITRAKVI | VITRAKVI | VITRAKVI | VITRAKVI 維泰凱 膠囊100毫克 | ヴァイトラックビカプセル100mg | ||
| 25 mg capsule | VITRAKVI | VITRAKVI | VITRAKVI | VITRAKVI | VITRAKVI 維泰凱 膠囊25毫克 | ヴァイトラックビカプセル100mg | ||
| 20 mg per mL / per unit basis not stated cannot compare liquid | VITRAKVI | Vitrakvi 20mg/ml oral solution | Vitrakvi 20mg/ml oral solution 維泰凱20毫克/毫升口服溶液 | |||||
| 20 mg/1 mL liquid | VITRAKVI | VITRAKVI | ||||||
| 2 %/1 mL other | ヴァイトラックビ内用液20mg/mL | |||||||
unknown | VITRAKVI | VITRAKVI Vitrakvi 20mg/ml oral solution | VITRAKVI |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in JP and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en JP que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 JP 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 JP 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.